Research
In vivo programming of dual-targeted CAR-T cells facilitates vascular disruption and T-cell infiltration in solid tumors
Nature ·
The Brief
- A study listed on nature.com describes in vivo programming of dual-targeted CAR-T cells for solid tumours.
- According to its title, the approach facilitates vascular disruption and T-cell infiltration in solid tumours.
- The source provided no summary, so methods and results beyond the title are not reported here.
Why it matters
Solid tumours have been harder to treat with CAR-T cell therapy than blood cancers, and the title suggests this work targets both tumour cells and tumour vasculature to help T cells enter tumours. Researchers in cancer immunotherapy may want to read the full paper to judge the evidence.
Who’s affected
- cancer immunotherapy researchers
- clinicians and developers working on CAR-T therapies for solid tumours
- #car-t
- #solid tumours
- #immunotherapy
- #in vivo
- #cancer